IAM
ABMD

Integre Asset Management’s Abiomed Inc ABMD Stock Holding History

Integre Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-17,754
Closed -$462K – 168
2014
Q1 		$462K Buy
17,754
+266
+2% +$7.36K 0.1% 137
2013
Q4 		$468K Buy
17,488
+1,966
+13% +$48.6K 0.11% 131
2013
Q3 		$296K Buy
15,522
+72
+0.5% +$1.65K 0.08% 156
2013
Q2 		$333K Buy
+15,450
New +$311K 0.09% 151

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Integre Asset Management's ABMD Position: Q2 2014 in Review

Integre Asset Management sold out of Abiomed Inc (ABMD) in Q2 2014, closing a stake of 17,754 shares — an estimated $462K sold.

Integre Asset Management first reported a position in ABMD in Q2 2013 and held it in 4 quarters. The position peaked at $468K in Q4 2013. 138 funds tracked by Wall St. Rank hold ABMD as of Q2 2014.

  • Integre Asset Management reported no remaining Abiomed Inc position as of Q2 2014 after selling out during the quarter.
  • Integre Asset Management sold 17,754 Abiomed Inc shares in Q2 2014, an estimated $462K.
  • Integre Asset Management first reported a position in Abiomed Inc in Q2 2013 and held it in 4 quarters.
  • Integre Asset Management's Abiomed Inc position peaked at $468K in Q4 2013.
  • 138 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2014.

Based on Integre Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.